Skip to content
Independent analysis of NHS open data
PharmaInsight

Dolutegravir/lamivudine vs Oseltamivir phosphate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Oseltamivir phosphate was dispensed 336.0× as often as Dolutegravir/lamivudine in April 2026 — 336 items versus 1 in England.

1items

Dolutegravir/lamivudine · April 2026

NHSBSA Prescription Cost Analysis

336items

Oseltamivir phosphate · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Dolutegravir/lamivudine versus Oseltamivir phosphate: national items dispensed by month

▬ Dolutegravir/lamivudine   ·   ╌ Oseltamivir phosphate

0 8k 15k Mar 2021 Mar 2023 Sep 2023 Apr 2024 Oct 2024 Apr 2025 Apr 2026 Oseltamivir phos… 1 Mar 2021: 1 Sep 2021: 1 Jan 2022: 1 Jun 2022: 2 Oct 2022: 2 Feb 2023: 1 Mar 2023: 2 Apr 2023: 1 May 2023: 3 Jun 2023: 1 Jul 2023: 2 Aug 2023: 3 Sep 2023: 2 Oct 2023: 2 Dec 2023: 1 Jan 2024: 2 Feb 2024: 2 Mar 2024: 6 Apr 2024: 1 May 2024: 3 Jun 2024: 3 Jul 2024: 2 Aug 2024: 2 Sep 2024: 2 Oct 2024: 1 Nov 2024: 3 Dec 2024: 1 Jan 2025: 4 Feb 2025: 3 Mar 2025: 3 Apr 2025: 1 May 2025: 2 Jun 2025: 2 Jul 2025: 1 Aug 2025: 2 Sep 2025: 3 Oct 2025: 2 Nov 2025: 3 Jan 2026: 2 Mar 2026: 1 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Dolutegravir/lamivudine versus Oseltamivir phosphate, April 2026
Measure Dolutegravir/lamivudine Oseltamivir phosphate
Items, April 2026 1 336
Items, last 12 months 23 37,292
Net ingredient cost, April 2026 £656 £5,074

See the full profile for Dolutegravir/lamivudine or Oseltamivir phosphate.